About: Shattuck Labs, Inc., a clinical-stage biotechnology company, engages in the development of antibodies for the treatment of inflammatory and immune-mediated diseases in the United States. The company develops SL-325, a death receptor 3 blocking monoclonal antibody, which is in Phase I clinical trial for the treatment of tumor necrosis factor like ligand 1A; and SL-425, a half-life extended version of SL-325, which is under IND-enabling chronic good laboratory practices toxicity study. It is also involved in the development of various preclinical DR3-based bispecific antibodies for the treatment of patients with inflammatory bowel disease or other immune-mediated indications; and TRIM7, an oncology-focused program. The company was incorporated in 2016 and is headquartered in Austin, Texas.
Sector: Healthcare
Industry: Biotechnology
Latest price: $5.66 (-3.50%)
STTK NASDAQ Shattuck Labs Inc
Shattuck Labs Inc share price
STTK price activity
Last Price
$5.660
Change (24hr)
-0.21 USD (-3.50%)
Volume
1.01M
Volume (4w avg)
-
Open
$5.76
Day Range
$5.55 - $5.83
Previous Close
$5.86
Last Trade
07 Oct, 8:00 pm GMT+0
Delayed
07 Oct, 8:00 pm GMT+0
STTK price performance
Delayed
07 Oct, 8:00 pm GMT+0
STTK Market Signals